ResMed (RMD) PT Bumped to $66 at Needham & Company Posts Q4

Go back to ResMed (RMD) PT Bumped to $66 at Needham & Company Posts Q4

ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015

July 30, 2015 4:06 PM EDT

SAN DIEGO, July 30, 2015 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended June 30, 2015.  Revenue for the quarter was $453.1 million, a 9 percent increase compared with the quarter ended June 30, 2014 (a 17 percent increase on a constant currency basis).  Net income was $87.5 million, consistent with the quarter ended June 30, 2014.  Diluted earnings per share for the quarter were $0.61, consistent with the quarter ended June 30, 2014. 

The results for the quarter ended June 30, 2015 were impacted by two non-recurring items: first, expenses of $5.0 million ($3.5 million, net of tax) associated with the field... More